Patent · US Active

Modified release preparations containing oxcarbazepine and derivatives thereof

US10220042B2 · kind B2 · utility

1Cited by

17References

27Claims

0Family size

Assignee

Supernus Pharmaceuticals, Inc. · US

Inventors

Padmanabh P. Bhatt · Rockville, US
Argaw Kidane · Montgomery Village, US
Kevin Edwards · Olive Branch, US

Key dates

Filing date	Dec 7, 2017
Grant date	Mar 5, 2019
Priority date	—
Expiry date	Dec 7, 2037

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K2800/56
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Controlled-release preparations of oxcarbazepine and derivatives thereof for once-a-day administration are disclosed. The inventive compositions comprise solubility- and/or release enhancing agents to provide tailored drug release profiles, preferably sigmoidal release profiles. Methods of treatment comprising the inventive compositions are also disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.